lactic acid has been researched along with Black Fever in 9 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oleanolic acid (OA) has low aqueous solubility and low permeability, which results poor bioavailability." | 1.43 | Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis. ( Bera, T; Ghosh, S; Kar, N, 2016) |
| "Treatment with artemisinin-loaded nanoparticles significantly reduced the number of amastigotes per macrophage and percent infected macrophages ex vivo compared to free artemisinin." | 1.40 | A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies. ( Afrin, F; Chattopadhyay, AP; Chouhan, G; Dasgupta, AK; Islamuddin, M; Want, MY, 2014) |
| "Amphotericin B was incorporated into poly(D, L-lactide-co-glycolide) nanoparticles, biodegradable drug carriers, to allow specific targeting inside the cell." | 1.29 | In vitro study of the anti-leishmanial activity of biodegradable nanoparticles. ( Benoit, JP; Monjour, L; Venier-Julienne, MC; Vouldoukis, I, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Want, MY | 1 |
| Islamuddin, M | 1 |
| Chouhan, G | 1 |
| Dasgupta, AK | 1 |
| Chattopadhyay, AP | 1 |
| Afrin, F | 1 |
| Marín, C | 1 |
| Ramírez-Macías, I | 1 |
| Rosales, MJ | 1 |
| Muro, B | 1 |
| Reviriego, F | 1 |
| Navarro, P | 1 |
| Arán, VJ | 1 |
| Sánchez-Moreno, M | 2 |
| Kumar, R | 1 |
| Sahoo, GC | 1 |
| Pandey, K | 1 |
| Das, VNR | 1 |
| Topno, RK | 1 |
| Ansari, MY | 1 |
| Rana, S | 1 |
| Das, P | 1 |
| Ghosh, S | 1 |
| Kar, N | 1 |
| Bera, T | 1 |
| Costa Lima, SA | 1 |
| Resende, M | 1 |
| Silvestre, R | 1 |
| Tavares, J | 1 |
| Ouaissi, A | 1 |
| Lin, PK | 1 |
| Cordeiro-da-Silva, A | 1 |
| Tyagi, R | 1 |
| Lala, S | 1 |
| Verma, AK | 1 |
| Nandy, AK | 1 |
| Mahato, SB | 1 |
| Maitra, A | 1 |
| Basu, MK | 1 |
| Sánchez-Brunete, JA | 1 |
| Dea, MA | 1 |
| Rama, S | 1 |
| Bolás, F | 1 |
| Alunda, JM | 1 |
| Torrado-Santiago, S | 1 |
| Torrado, JJ | 1 |
| Venier-Julienne, MC | 1 |
| Vouldoukis, I | 1 |
| Monjour, L | 1 |
| Benoit, JP | 1 |
| Mesa, C | 1 |
| Rodriguez-Cabezas, N | 1 |
| Castilla, JJ | 1 |
| Moraleda-Lindez, V | 1 |
| Barbe, J | 1 |
| Osuna, A | 1 |
9 other studies available for lactic acid and Black Fever
| Article | Year |
|---|---|
A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Con | 2014 |
In vitro leishmanicidal activity of 1,3-disubstituted 5-nitroindazoles.
Topics: Acetates; Alanine; Animals; Antiprotozoal Agents; Glycine; In Vitro Techniques; Indazoles; Lactic Ac | 2015 |
Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis.
Topics: Animals; Cricetinae; Drug Delivery Systems; Lactic Acid; Leishmania donovani; Leishmaniasis, Viscera | 2016 |
Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
Topics: Animals; Drug Carriers; Drug Evaluation, Preclinical; Female; Inhibitory Concentration 50; Lactic Ac | 2016 |
Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies.
Topics: Animals; Antiprotozoal Agents; Cell Line; Drug Carriers; Humans; Lactic Acid; Leishmania donovani; L | 2012 |
Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis.
Topics: Animals; Antiparasitic Agents; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Chemistr | 2005 |
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B.
Topics: Albumins; Amphotericin B; Animals; Antigens, Protozoan; Antiprotozoal Agents; Cricetinae; Drug Carri | 2005 |
In vitro study of the anti-leishmanial activity of biodegradable nanoparticles.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Biocompatible Materials; Cell Survival; Drug Carriers | 1995 |
In vitro and in vivo activities of three acridine thioethers against Leishmania donovani.
Topics: Acetates; Acridines; Animals; Antiprotozoal Agents; Cell Division; Cell Line; Dose-Response Relation | 2002 |